Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for MDGL. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 1,200,770 | $645M | DECREASED |
| State Street | 527,057 | $283M | DECREASED |
| Pictet Asset Management Holding | 192,896 | $103M | INCREASED |
| BNY Mellon | 128,520 | $69M | DECREASED |
| Assenagon Asset Management | 124,214 | $67M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| William John Sibold (President and CEO) | EXERCISE | 50,000 | 2026-07-17 | |
| William John Sibold (President and CEO) | SELL | 280 | $155K | 2026-07-17 |
| William John Sibold (President and CEO) | SELL | 1 | $550 | 2026-07-17 |
| William John Sibold (President and CEO) | SELL | 153 | $84K | 2026-07-17 |
| William John Sibold (President and CEO) | SELL | 47 | $26K | 2026-07-17 |
Full institutional holdings, insider history, and congressional trades for Madrigal Pharmaceuticals, Inc. Common Stock on SentiSense.